The 2022 edition of Farmaforum continues to expand the content of its cycle of conferences. Cannabisforum is the new initiative of the fair dedicated to the industrial production of different pharmaceutical products based on and derived from cannabis.
It is increasingly common to find products containing cannabidiol, a non-psychoactive natural compound present in cannabis, in the pharmaceutical and cosmetic industry. Currently, more than thirty countries have legalized the therapeutic use of cannabis extracts and it is estimated that at least a dozen more will do so in the coming years. Given this global framework, which is increasingly favorable to the legal production and sale of cannabis derivatives, the therapeutic cannabis industry sees a huge potential market, valued at billions of dollars. In fact, some estimates place the growth rate of the medical cannabis industry at 16% per year for the next few years and a turnover of around 2.7 billion euros in Europe.
This new section of Farmaforum intends to publicize the pharmaceutical manufacturing processes based on CBD (cannabidiol). This substance is used to combat certain types of pain or in certain treatments to treat diseases such as epilepsy.
The Cannabisforum conference cycle will take place on October 6th, 2022 within the framework of the Farmaforum fair.